ESSA Pharma Inc.
EPIXDelisted Oct 9, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001633932
ESSA Pharma Inc. was delisted on Oct 9, 2025; its insiders filed their last Form 4 on Oct 15, 2025; 32 institutions reported holding it in 13F filings for Q3 2025, worth $4.30M in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in ESSA Pharma Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 54
- −5 vs. Q2 2022
- Shares held
- 33.8M
- −3.98M (−10.5%) vs. Q2 2022
- Total value
- $62.2M
- −$56.8M (−47.8%) vs. Q2 2022
- New holders
- 10
- 13 more added
- Sold out
- 15
- 15 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EPIX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 32 | $4.30M |
| Q2 2025 | 36 | $52.7M |
| Q1 2025 | 36 | $50.1M |
| Q4 2024 | 45 | $58.8M |
| Q3 2024 | 32 | $212.7M |
| Q2 2024 | 31 | $185.1M |
| Q1 2024 | 33 | $297.5M |
| Q4 2023 | 31 | $229.4M |
| Q3 2023 | 36 | $103.4M |
| Q2 2023 | 39 | $89.8M |
| Q1 2023 | 37 | $98.3M |
| Q4 2022 | 45 | $84.1M |
| Q3 2022 | 54 | $62.2M |
| Q2 2022 | 59 | $119.0M |
| Q1 2022 | 70 | $229.9M |
| Q4 2021 | 60 | $530.1M |
| Q3 2021 | 75 | $297.4M |
| Q2 2021 | 80 | $976.0M |
| Q1 2021 | 70 | $895.7M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding ESSA Pharma Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BVF Inc | 8,748,629 | $15.9M | 0.66% | +5,050,000+136.5% | Added |
| Bellevue Group AG | 5,898,583 | $10.7M | 0.15% | +888,869+17.7% | Added |
| Soleus Capital Management, L.P. | 2,640,539 | $4.81M | 0.65% | −1,528,260−36.7% | Reduced |
| Avidity Partners Management LP | 2,460,000 | $4.48M | 0.10% | 00.0% | Unchanged |
| Morgan Stanley | 2,106,019 | $3.83M | 0.00% | −1,563,661−42.6% | Reduced |
| Eventide Asset Management, LLC | 1,561,251 | $2.84M | 0.06% | −1,804,317−53.6% | Reduced |
| PFM Health Sciences, LP | 1,478,252 | $2.69M | 0.10% | +516,536+53.7% | Added |
| RTW Investments, LP | 1,311,294 | $2.39M | 0.06% | −1,325,898−50.3% | Reduced |
| Adage Capital Partners GP, L.L.C. | 1,042,531 | $1.90M | 0.00% | 00.0% | Unchanged |
| Rhenman & Partners Asset Management AB | 375,000 | $1.35M | 0.14% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 692,910 | $1.26M | 0.10% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 640,645 | $1.17M | 0.02% | +640,645 | New |
| Rock Springs Capital Management LP | 524,944 | $955.0K | 0.02% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 499,833 | $910.0K | 0.00% | +159,207+46.7% | Added |
| Candriam Luxembourg S.C.A. | 417,532 | $760.0K | 0.01% | −149,811−26.4% | Reduced |
| Millennium Management LLC | 406,761 | $740.0K | 0.00% | +80,031+24.5% | Added |
| MPM Oncology Impact Management LP | 405,700 | $738.0K | 0.17% | −255,192−38.6% | Reduced |
| Woodline Partners LP | 382,282 | $696.0K | 0.01% | +382,282 | New |
| Two Sigma Investments, LP | 347,758 | $633.0K | 0.00% | +296,302+575.8% | Added |
| Two Sigma Advisers, LP | 342,400 | $623.0K | 0.00% | +291,300+570.1% | Added |
| Omega Fund Management, LLC | 328,196 | $597.0K | 0.22% | 00.0% | Unchanged |
| Walleye Capital LLC | 237,153 | $432.0K | 0.01% | +132,760+127.2% | Added |
| Renaissance Technologies LLC | 185,910 | $338.0K | 0.00% | +160,310+626.2% | Added |
| Marshall Wace, LLP | 115,122 | $209.0K | 0.00% | +93,729+438.1% | Added |
| CIBC World Markets Inc. | 77,236 | $141.0K | 0.00% | −17,342−18.3% | Reduced |
| JPMorgan Chase & Co | 73,668 | $134.0K | 0.00% | −206,057−73.7% | Reduced |
| Acadian Asset Management LLC | 72,046 | $129.0K | 0.00% | +72,046 | New |
| Cubist Systematic Strategies, LLC | 55,614 | $101.0K | 0.00% | +25,715+86.0% | Added |
| Price T Rowe Associates Inc | 44,832 | $82.0K | 0.00% | −74,619−62.5% | Reduced |
| Raymond James & Associates | 40,619 | $74.0K | 0.00% | 00.0% | Unchanged |
| AlpInvest Partners B.V. | 39,930 | $73.0K | 0.02% | −66,461−62.5% | Reduced |
| Thrivent Financial for Lutherans | 31,337 | $56.0K | 0.00% | +31,337 | New |
| State Street Corp | 24,851 | $45.0K | 0.00% | −5,860−19.1% | Reduced |
| Goldman Sachs Group Inc | 24,531 | $45.0K | 0.00% | +12,792+109.0% | Added |
| Alps Advisors Inc | 24,052 | $44.0K | 0.00% | −2,088−8.0% | Reduced |
| XTX Topco Ltd | 23,338 | $42.0K | 0.01% | +23,338 | New |
| Susquehanna International Group, LLP | 19,872 | $36.0K | 0.00% | +19,872 | New |
| Geode Capital Management, LLC | 19,039 | $34.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 16,760 | $30.0K | 0.00% | −5,208−23.7% | Reduced |
| Northern Trust Corp | 11,868 | $22.0K | 0.00% | +199+1.7% | Added |
| Alta Wealth Advisors LLC | 11,285 | $21.0K | 0.02% | 00.0% | Unchanged |
| Hunting Hill Global Capital, LLC | 10,000 | $18.0K | 0.01% | +10,000 | New |
| Bessemer Group Inc | 6,852 | $12.0K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 5,765 | $10.0K | 0.00% | −1,630−22.0% | Reduced |
| Advisor Group Holdings, Inc. | 4,225 | $8.00K | 0.00% | 00.0% | Unchanged |
| Aquatic Capital Management LLC | 3,300 | $6.00K | 0.00% | +3,300 | New |
| Quantbot Technologies LP | 2,151 | $3.00K | 0.00% | +2,151 | New |
| TD Waterhouse Canada Inc. | 900 | $1.59K | 0.00% | 00.0% | Unchanged |
| Laurel Wealth Advisors LLC | 600 | $1.00K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 50 | $91 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 8 | $0 | 0.00% | −8,656−99.9% | Reduced |
| Crewe Advisors LLC | 265 | $0 | 0.00% | 00.0% | Unchanged |
| Newbridge Financial Services Group, Inc. | 31 | $0 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 350 | $0 | 0.00% | +350 | New |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −2,909,410−100.0% | Sold out |
| Blackstone Group Inc. | 0 | $0 | 0.00% | −2,003,103−100.0% | Sold out |
| Boxer Capital, LLC | 0 | $0 | 0.00% | −724,500−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −53,443−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −40,421−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −28,551−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −26,282−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −26,146−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −19,147−100.0% | Sold out |
| Values First Advisors, Inc. | 0 | $0 | 0.00% | −14,605−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −11,353−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −599−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −48−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −132−100.0% | Sold out |